Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,321 | 136 | 97.3% |
| Education | $65.36 | 9 | 2.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $432.19 | 26 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $399.80 | 15 | $0 (2024) |
| Novo Nordisk Inc | $380.99 | 34 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $275.59 | 17 | $0 (2019) |
| PFIZER INC. | $130.99 | 7 | $0 (2024) |
| Abbott Laboratories | $113.49 | 7 | $0 (2023) |
| Amgen Inc. | $87.27 | 5 | $0 (2024) |
| Allergan Inc. | $68.10 | 5 | $0 (2019) |
| Phathom Pharmaceuticals, Inc. | $65.82 | 3 | $0 (2024) |
| Astellas Pharma US Inc | $65.67 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $511.26 | 26 | AstraZeneca Pharmaceuticals LP ($117.12) |
| 2023 | $316.25 | 19 | GlaxoSmithKline, LLC. ($67.32) |
| 2022 | $58.13 | 4 | Bayer HealthCare Pharmaceuticals Inc. ($27.20) |
| 2021 | $43.31 | 2 | Abbott Laboratories ($22.20) |
| 2019 | $888.84 | 49 | AstraZeneca Pharmaceuticals LP ($232.76) |
| 2018 | $542.11 | 43 | Novo Nordisk Inc ($183.61) |
| 2017 | $26.03 | 2 | Astellas Pharma US Inc ($15.39) |
All Payment Transactions
145 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Endocrinology | ||||||
| 12/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: Inflammation | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: RESPIRATORY | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: Respiratory | ||||||
| 08/27/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Bone Health | ||||||
| 08/20/2024 | ACADIA Pharmaceuticals Inc | DAYBUE (Drug) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: RETT SYNDROME | ||||||
| 08/13/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: ANTIBIOTIC | ||||||
| 07/25/2024 | ACADIA Pharmaceuticals Inc | DAYBUE (Drug) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: RETT SYNDROME | ||||||
| 07/10/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: Endocrinology | ||||||
| 06/27/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Biological | ||||||
| 05/07/2024 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: Drug Infusion Systems | ||||||
| 04/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Cardio-renal | ||||||
| 03/19/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: Cardio-renal | ||||||
| 02/29/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Respiratory | ||||||
| 02/28/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $25.69 | General |
| Category: RESPIRATORY | ||||||
| 02/22/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Respiratory | ||||||
| 02/08/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Inflammation | ||||||
| 02/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/06/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 977 | 1,260 | $294,492 | $96,162 |
| 2022 | 13 | 908 | 1,294 | $279,640 | $86,311 |
| 2021 | 9 | 734 | 1,223 | $275,266 | $79,764 |
| 2020 | 16 | 1,068 | 1,558 | $307,009 | $77,970 |
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 334 | 614 | $128,332 | $34,225 | 26.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 250 | 250 | $83,873 | $31,491 | 37.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 39 | 39 | $18,018 | $11,033 | 61.2% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2023 | 15 | 15 | $5,100 | $3,792 | 74.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 20 | 20 | $9,659 | $3,242 | 33.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 15 | 15 | $7,467 | $2,427 | 32.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 51 | 51 | $15,891 | $2,406 | 15.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 65 | 65 | $1,625 | $1,593 | 98.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 20 | 20 | $6,217 | $1,569 | 25.2% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 17 | 17 | $3,876 | $1,280 | 33.0% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 60 | 63 | $8,694 | $1,192 | 13.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 25 | 25 | $625.00 | $612.50 | 98.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 12 | 12 | $2,964 | $600.44 | 20.3% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 25 | 25 | $1,425 | $546.69 | 38.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 29 | 29 | $726.45 | $153.12 | 21.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 418 | 801 | $167,417 | $41,544 | 24.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 155 | 155 | $52,001 | $19,693 | 37.9% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2022 | 39 | 39 | $13,260 | $9,829 | 74.1% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 73 | 74 | $10,212 | $2,909 | 28.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 45 | 45 | $14,021 | $2,645 | 18.9% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 19 | 19 | $3,990 | $2,491 | 62.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 15 | 15 | $7,245 | $2,449 | 33.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 15 | 16 | $4,973 | $1,594 | 32.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 57 | 57 | $1,425 | $1,402 | 98.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 12 | 13 | $3,211 | $841.32 | 26.2% |
About Dr. Munira Khambati, M.D
Dr. Munira Khambati, M.D is a Family Medicine healthcare provider based in Marble Falls, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1215958624.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Munira Khambati, M.D has received a total of $2,386 in payments from pharmaceutical and medical device companies, with $511.26 received in 2024. These payments were reported across 145 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,321).
As a Medicare-enrolled provider, Khambati has provided services to 3,687 Medicare beneficiaries, totaling 5,335 services with total Medicare billing of $340,207. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Marble Falls, TX
- Active Since 07/21/2006
- Last Updated 09/11/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1215958624
Products in Payments
- TRELEGY ELLIPTA (Drug) $308.40
- Ozempic (Drug) $215.71
- TOUJEO (Drug) $136.55
- FARXIGA (Drug) $122.19
- SOLIQUA 100/33 (Drug) $115.85
- SYMBICORT (Drug) $106.12
- ANORO (Drug) $96.57
- Tresiba (Drug) $85.60
- LYRICA (Drug) $72.93
- Otezla (Drug) $67.11
- VOQUEZNA (Drug) $65.82
- Kerendia (Drug) $63.42
- Cologuard Collection Kit (Device) $62.20
- Dexcom G6 Transmitter (Medical Supply) $56.40
- Victoza (Drug) $52.66
- AIRSUPRA (Drug) $51.49
- Veozah (Drug) $50.28
- DAYBUE (Drug) $44.46
- CHANTIX (Drug) $40.40
- LINZESS (Drug) $32.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Marble Falls
Jara Mcdonald, M.d, M.D
Family Medicine — Payments: $10,701
Dr. Amy Van Dorfy, Md, MD
Family Medicine — Payments: $3,732
Dr. Peter Gosselink, Md, MD
Family Medicine — Payments: $3,067
Stephen Little, Md, MD
Family Medicine — Payments: $1,633
Sandra George, Do, DO
Family Medicine — Payments: $1,450
Hilary Kieffer, Md, MD
Family Medicine — Payments: $409.82